Skip to main content
Top
Published in: Drugs & Aging 7/2012

01-07-2012 | Original Research Article

Hospitalization as a Turning Point for Sleep Medication Use in Older Adults

Prospective Cohort Study

Authors: Dr Anna Zisberg, Efrat Shadmi, Gary Sinoff, Nurit Gur-Yaish, Einav Srulovici, Tamar Shochat

Published in: Drugs & Aging | Issue 7/2012

Login to get access

Abstract

Background

Use of sleep medications as a result of hospitalization among older adults is common and has been shown to result in chronic use and increased risks for adverse effects such as falls and cognitive decline. However, few studies have explored in-hospital sleep medication use or disuse as a possible factor related to subsequent home use.

Objective

The aim of this study was to examine changes in sleep medication use pre- to post-hospitalization as a function of in-hospital use. Methods: The study was designed as a prospective cohort study, and included 485 acute medical patients aged 70 years and older, hospitalized in a large, Israeli, teaching medical centre. Sleep medication use was assessed by patient interviews regarding patterns of use prior to, during and at 1 and 3 months after discharge. Post-discharge using patterns were assessed as a function of in-hospital discontinuation or initiation of sleep medications; background demographic and clinical characteristics were assessed as well. Logistic regressions were modelled separately for discontinuation and initiation of sleep medication use at each follow-up.

Results

Of those patients who used sleep medications prior to admission, 37 (18% of 206 prior users) discontinued use during the hospital stay. Non-use of sleep medications during hospitalization was the main significant characteristic associated with post-hospitalization discontinuation among prior users, when comparing patients who continued with those who discontinued using sleep medications in bivariate analyses. Discontinuation was associated with an adjusted odds ratio (AOR, adjusted for cognitive status) of 3.91 (95% confidence interval [CI] 1.64, 9.30) for non-use at the 1-month follow-up. Of those who did not use sleep medications prior to admission, 39 (14% of 279 non-prior users) initiated use during hospitalization. Again, sleep medication initiation at time of hospitalization was the main correlate of change in post-hospitalization medication use status, when comparing post-discharge users and non-users, among the non-prior users. Hospital initiation of sleep medications was associated with an AOR (adjusted for levels of education and morbidity, readmission, and functional status) of 4.65 (95% CI 1.95, 11.09) for post-discharge use. Similar results were obtained for the 3-month follow-up, reaching significance levels only for the discontinuation group.

Conclusions

Though overall prevalence rates of sleep medication use pre-and post-hospitalization are fairly similar, rigorous scrutiny of the findings demonstrates that in-hospital sleep medication use and disuse may be a significant turning point both for initiation and discontinuation of sleep medications, especially in the short post-discharge time frame. Thus, in-hospital sleep medication prescribing policies should acknowledge the potential for changes in the post-discharge sleep medication regimen.
Literature
1.
go back to reference Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998 Apr; 13 (4): 243–50.PubMedCentralPubMedCrossRef Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998 Apr; 13 (4): 243–50.PubMedCentralPubMedCrossRef
2.
go back to reference Blumstein T, Benyamini Y, Chetrit A, et al. Prevalence and correlates of psychotropic medication use among older adults in Israel: cross-sectional and longitudinal findings from two cohorts a decade apart. Aging Ment Health. Epub 2012 Feb 7. Blumstein T, Benyamini Y, Chetrit A, et al. Prevalence and correlates of psychotropic medication use among older adults in Israel: cross-sectional and longitudinal findings from two cohorts a decade apart. Aging Ment Health. Epub 2012 Feb 7.
3.
go back to reference Beland SG, Preville M, Dubois MF, et al. The association between length of benzodiazepine use and sleep quality in older population. Int J Geriatr Psychiatry 2011 Sep; 26 (9): 908–15.PubMedCrossRef Beland SG, Preville M, Dubois MF, et al. The association between length of benzodiazepine use and sleep quality in older population. Int J Geriatr Psychiatry 2011 Sep; 26 (9): 908–15.PubMedCrossRef
4.
go back to reference Bazin F, Noize P, Dartigues JF, et al. Engagement in leisure activities and benzodiazepine use in a French community-dwelling elderly population. Int J Geriatr Psychiatry. Epub 2011 Aug 31. Bazin F, Noize P, Dartigues JF, et al. Engagement in leisure activities and benzodiazepine use in a French community-dwelling elderly population. Int J Geriatr Psychiatry. Epub 2011 Aug 31.
5.
go back to reference Gisev N, Hartikainen S, Chen TF, et al. Mortality associated with benzodiazepines and benzodiazepine-related drugs among community-dwelling older people in Finland: a population-based retrospective cohort study. Can J Psychiatry 2011 Jun; 56 (6): 377–81.PubMed Gisev N, Hartikainen S, Chen TF, et al. Mortality associated with benzodiazepines and benzodiazepine-related drugs among community-dwelling older people in Finland: a population-based retrospective cohort study. Can J Psychiatry 2011 Jun; 56 (6): 377–81.PubMed
6.
go back to reference Windle A, Elliot E, Duszynski K, et al. Benzodiazepine prescribing in elderly Australian general practice patients. Aust N Z J Public Health 2007 Aug; 31 (4): 379–81.PubMedCrossRef Windle A, Elliot E, Duszynski K, et al. Benzodiazepine prescribing in elderly Australian general practice patients. Aust N Z J Public Health 2007 Aug; 31 (4): 379–81.PubMedCrossRef
7.
go back to reference Howes JB, Ryan J, Fairbrother G, et al. Benzodiazepine prescribing in a Sydney teaching hospital. Med J Aust 1996 Sep 16; 165 (6): 305–8.PubMed Howes JB, Ryan J, Fairbrother G, et al. Benzodiazepine prescribing in a Sydney teaching hospital. Med J Aust 1996 Sep 16; 165 (6): 305–8.PubMed
8.
go back to reference Zisselman MH, Rovner BW, Yuen EJ, et al. Physician rationale for benzodiazepine prescriptions to elderly hospitalized patients. Am J Geriatr Psychiatry 1997 Spring; 5 (2): 167–71.PubMedCrossRef Zisselman MH, Rovner BW, Yuen EJ, et al. Physician rationale for benzodiazepine prescriptions to elderly hospitalized patients. Am J Geriatr Psychiatry 1997 Spring; 5 (2): 167–71.PubMedCrossRef
9.
go back to reference Pisani MA, Murphy TE, Araujo KL, et al. Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population. Crit Care Med 2009 Jan; 37 (1): 177–83.PubMedCentralPubMedCrossRef Pisani MA, Murphy TE, Araujo KL, et al. Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population. Crit Care Med 2009 Jan; 37 (1): 177–83.PubMedCentralPubMedCrossRef
10.
go back to reference Catic AG. Identification and management of in-hospital drug-induced delirium in older patients. Drugs Aging 2011; 28 (9): 737–48.PubMedCrossRef Catic AG. Identification and management of in-hospital drug-induced delirium in older patients. Drugs Aging 2011; 28 (9): 737–48.PubMedCrossRef
11.
go back to reference Tamblyn R, Abrahamowicz M, du Berger R, et al. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc 2005 Feb; 53 (2): 233–41.PubMedCrossRef Tamblyn R, Abrahamowicz M, du Berger R, et al. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc 2005 Feb; 53 (2): 233–41.PubMedCrossRef
12.
go back to reference Gray SL, LaCroix AZ, Hanlon JT, et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 2006 Feb; 54 (2): 224–30.PubMedCentralPubMedCrossRef Gray SL, LaCroix AZ, Hanlon JT, et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 2006 Feb; 54 (2): 224–30.PubMedCentralPubMedCrossRef
13.
go back to reference Pariente A, Dartigues JF, Benichou J, et al. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008; 25 (1): 61–70.PubMedCrossRef Pariente A, Dartigues JF, Benichou J, et al. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008; 25 (1): 61–70.PubMedCrossRef
14.
go back to reference Rikala M, Korhonen MJ, Sulkava R, et al. Psychotropic drug use in community-dwelling elderly people: characteristics of persistent and incident users. Eur J Clin Pharmacol 2011; 67 (7): 731–9.PubMedCrossRef Rikala M, Korhonen MJ, Sulkava R, et al. Psychotropic drug use in community-dwelling elderly people: characteristics of persistent and incident users. Eur J Clin Pharmacol 2011; 67 (7): 731–9.PubMedCrossRef
15.
go back to reference Terzano MG, Rossi M, Palomba V, et al. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 2003; 26 (4): 261–82.PubMedCrossRef Terzano MG, Rossi M, Palomba V, et al. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 2003; 26 (4): 261–82.PubMedCrossRef
16.
go back to reference Finkle WD, Der JS, Greenland S, et al. Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc 2011 Oct; 59 (10): 1883–90.PubMedCrossRef Finkle WD, Der JS, Greenland S, et al. Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc 2011 Oct; 59 (10): 1883–90.PubMedCrossRef
17.
go back to reference Mattila MJ, Vanakoski J, Kalska H, et al. Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory. Pharmacol Biochem Behav 1998 Apr; 59 (4): 917–23.PubMedCrossRef Mattila MJ, Vanakoski J, Kalska H, et al. Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory. Pharmacol Biochem Behav 1998 Apr; 59 (4): 917–23.PubMedCrossRef
18.
go back to reference Morgan PT, Kehne JH, Sprenger KJ, et al. Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans. J Sleep Res 2010 Mar; 19 (1 Pt 2): 157–64.PubMedCrossRef Morgan PT, Kehne JH, Sprenger KJ, et al. Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans. J Sleep Res 2010 Mar; 19 (1 Pt 2): 157–64.PubMedCrossRef
19.
go back to reference Chang CM, Chen MJ, Tsai CY, et al. Medical conditions and medications as risk factors of falls in the inpatient older people: a case-control study. Int J Geriatr Psychiatry 2011 Jun; 26 (6): 602–7.PubMedCrossRef Chang CM, Chen MJ, Tsai CY, et al. Medical conditions and medications as risk factors of falls in the inpatient older people: a case-control study. Int J Geriatr Psychiatry 2011 Jun; 26 (6): 602–7.PubMedCrossRef
20.
go back to reference Iwata M, Kuzuya M, Kitagawa Y, et al. Underappreciated predictors for postdischarge mortality in acute hospitalized oldest-old patients. Gerontology 2006; 52 (2): 92–8.PubMedCrossRef Iwata M, Kuzuya M, Kitagawa Y, et al. Underappreciated predictors for postdischarge mortality in acute hospitalized oldest-old patients. Gerontology 2006; 52 (2): 92–8.PubMedCrossRef
21.
go back to reference Stuffken R, van Hulten RP, Heerdink ER, et al. The impact of hospitalisation on the initiation and long-term use of benzodiazepines. Eur J Clin Pharmacol 2005 Jun; 61 (4): 291–5.PubMedCrossRef Stuffken R, van Hulten RP, Heerdink ER, et al. The impact of hospitalisation on the initiation and long-term use of benzodiazepines. Eur J Clin Pharmacol 2005 Jun; 61 (4): 291–5.PubMedCrossRef
22.
23.
go back to reference Halfens R, Cox K, Kuppen-Van Merwijk A. Effect of the use of sleep medication in Dutch hospitals on the use of sleep medication at home. J Adv Nurs 1994 Jan; 19 (1): 66–70.PubMedCrossRef Halfens R, Cox K, Kuppen-Van Merwijk A. Effect of the use of sleep medication in Dutch hospitals on the use of sleep medication at home. J Adv Nurs 1994 Jan; 19 (1): 66–70.PubMedCrossRef
26.
go back to reference Millar HL, Clunie FS, McGilchrist MM, et al. The impact on community benzodiazepine prescribing of hospitalization. J Psychosom Res 1997 Jan; 42 (1): 61–9.PubMedCrossRef Millar HL, Clunie FS, McGilchrist MM, et al. The impact on community benzodiazepine prescribing of hospitalization. J Psychosom Res 1997 Jan; 42 (1): 61–9.PubMedCrossRef
27.
go back to reference Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975 Oct; 23 (10): 433–41.PubMed Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975 Oct; 23 (10): 433–41.PubMed
28.
go back to reference Covinsky KE, Palmer RM, Fortinsky RH, et al. Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc 2003 Apr; 51 (4): 451–8.PubMedCrossRef Covinsky KE, Palmer RM, Fortinsky RH, et al. Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc 2003 Apr; 51 (4): 451–8.PubMedCrossRef
29.
go back to reference Zisberg A, Shadmi E, Sinoff G, et al. Low mobility during hospitalization and functional decline in older adults. J Am Geriatr Soc 2011 Feb; 59 (2): 266–73.PubMedCrossRef Zisberg A, Shadmi E, Sinoff G, et al. Low mobility during hospitalization and functional decline in older adults. J Am Geriatr Soc 2011 Feb; 59 (2): 266–73.PubMedCrossRef
30.
go back to reference National Institutes of Health. National Institutes of Health state of the Science Conference Statement on manifestations and management of chronic insomnia in adults, June 13–15, 2005. Sleep 2005 Sep; 28 (9): 1049–57. National Institutes of Health. National Institutes of Health state of the Science Conference Statement on manifestations and management of chronic insomnia in adults, June 13–15, 2005. Sleep 2005 Sep; 28 (9): 1049–57.
32.
go back to reference Allen KD, Renner JB, DeVellis B, et al. Racial differences in sleep medication use: a cross-sectional study of the Johnston County Osteoarthritis Project. Ann Pharmacother 2008 Sep; 42 (9): 1239–46.PubMedCentralPubMedCrossRef Allen KD, Renner JB, DeVellis B, et al. Racial differences in sleep medication use: a cross-sectional study of the Johnston County Osteoarthritis Project. Ann Pharmacother 2008 Sep; 42 (9): 1239–46.PubMedCentralPubMedCrossRef
33.
go back to reference Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (5): 373–83.PubMedCrossRef Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (5): 373–83.PubMedCrossRef
34.
go back to reference Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985 Oct; 13(10): 818–29.PubMedCrossRef Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985 Oct; 13(10): 818–29.PubMedCrossRef
35.
go back to reference Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel index for stroke rehabilitation. J Clin Epidemiol 1989; 42 (8): 703–9.PubMedCrossRef Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel index for stroke rehabilitation. J Clin Epidemiol 1989; 42 (8): 703–9.PubMedCrossRef
36.
go back to reference Sinoff G, Ore L. The Barthel activities of daily living index: self-reporting versus actual performance in the old-old (> or=75 years). J Am Geriatr Soc 1997 Jul; 45 (7): 832–6.PubMed Sinoff G, Ore L. The Barthel activities of daily living index: self-reporting versus actual performance in the old-old (> or=75 years). J Am Geriatr Soc 1997 Jul; 45 (7): 832–6.PubMed
37.
go back to reference Fagnoni P, Limat S, Haffen E, et al. Does hospitalisation affect hypnotic and anxiolytic drug prescribing? Pharm World Sci 2007 Dec; 29 (6): 611–8.PubMedCrossRef Fagnoni P, Limat S, Haffen E, et al. Does hospitalisation affect hypnotic and anxiolytic drug prescribing? Pharm World Sci 2007 Dec; 29 (6): 611–8.PubMedCrossRef
38.
go back to reference Zisberg A, Gur-Yaish N, Shochat T. Contribution of routine to sleep quality in community elderly. Sleep 2010 Apr; 33 (4): 509–14.PubMedCentralPubMed Zisberg A, Gur-Yaish N, Shochat T. Contribution of routine to sleep quality in community elderly. Sleep 2010 Apr; 33 (4): 509–14.PubMedCentralPubMed
39.
go back to reference van der Hooft CS, Jong GW, Dieleman JP, et al. Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria — a population-based cohort study. Br J Clin Pharmacol 2005 Aug; 60 (2): 137–44.PubMedCentralPubMedCrossRef van der Hooft CS, Jong GW, Dieleman JP, et al. Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria — a population-based cohort study. Br J Clin Pharmacol 2005 Aug; 60 (2): 137–44.PubMedCentralPubMedCrossRef
40.
go back to reference Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007 Apr; 32 (2): 113–21.PubMedCrossRef Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007 Apr; 32 (2): 113–21.PubMedCrossRef
41.
go back to reference de Gier N, Gorgels W, Lucassen P, et al. Discontinuation of long-term benzodiazepine use: 10-year follow-up. Fam Pract 2011 Jun; 28 (3): 253–9.PubMedCrossRef de Gier N, Gorgels W, Lucassen P, et al. Discontinuation of long-term benzodiazepine use: 10-year follow-up. Fam Pract 2011 Jun; 28 (3): 253–9.PubMedCrossRef
42.
go back to reference Fisher J, Sanyal C, Frail D, et al. The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature. J Clin Pharm Ther 2012; 37 (1): 7–21.PubMedCrossRef Fisher J, Sanyal C, Frail D, et al. The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature. J Clin Pharm Ther 2012; 37 (1): 7–21.PubMedCrossRef
43.
go back to reference Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA division of geriatric medicine. Arch Intern Med. 1991 Sep; 151 (9): 1825–32.PubMedCrossRef Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA division of geriatric medicine. Arch Intern Med. 1991 Sep; 151 (9): 1825–32.PubMedCrossRef
44.
go back to reference Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000 Mar; 34 (3): 338–46.PubMedCrossRef Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000 Mar; 34 (3): 338–46.PubMedCrossRef
45.
go back to reference Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003 Dec 8–22; 163 (22): 2716–24.PubMedCrossRef Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003 Dec 8–22; 163 (22): 2716–24.PubMedCrossRef
46.
go back to reference Wagner AK, Soumerai SB, Zhang F, et al. Effects of state surveillance on new post-hospitalization benzodiazepine use. Int J Qual Health Care 2003 Oct; 15 (5): 423–31.PubMedCrossRef Wagner AK, Soumerai SB, Zhang F, et al. Effects of state surveillance on new post-hospitalization benzodiazepine use. Int J Qual Health Care 2003 Oct; 15 (5): 423–31.PubMedCrossRef
Metadata
Title
Hospitalization as a Turning Point for Sleep Medication Use in Older Adults
Prospective Cohort Study
Authors
Dr Anna Zisberg
Efrat Shadmi
Gary Sinoff
Nurit Gur-Yaish
Einav Srulovici
Tamar Shochat
Publication date
01-07-2012
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 7/2012
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/BF03262274

Other articles of this Issue 7/2012

Drugs & Aging 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine